Evaluating the value of continuing docetaxel and prednisone (DP) beyond 10 cycles in men with metastatic castration-resistant prostate cancer (mCRPC).

Journal Article

Full Text

Duke Authors

Cited Authors

  • Pond, GR; Armstrong, AJ; Wood, BA; Brookes, M; Leopold, LH; Berry, WR; De Wit, R; Eisenberger, MA; Tannock, I; Sonpavde, G

Published Date

  • May 20, 2011

Published In

Volume / Issue

  • 29 / 15_suppl

Start / End Page

  • 4582 - 4582

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2011.29.15_suppl.4582


  • en